Akums Drugs & Pharmaceuticals Ltd., a key player in India’s contract drug manufacturing space, has caught the attention of investors after global brokerage firm Citi reaffirmed its bullish stance. With a target price of Rs 700 per share, the stock could deliver a potential 36% upside from current levels. But does it justify a buy?
Stock Holding Steady Despite Market Volatility
Shares of Akums Drugs & Pharmaceuticals Ltd. were trading at Rs 516 per share on Thursday, reflecting a marginal dip of 0.2% from the previous day’s close. The company’s market capitalization stood at Rs 8,229.97 crore, solidifying its presence as a dominant contract development and manufacturing organization (CDMO) in the Indian pharma sector.
While broader market fluctuations have weighed on sentiment, Citi remains optimistic. The firm believes the company’s long-term growth potential outweighs short-term concerns, particularly given its latest contract wins and international expansion plans.
What’s Driving the 36% Upside?
A major catalyst for Citi’s bullish call is Akums’ recent 200-million-euro CDMO contract with a global pharmaceutical player. The company has already secured half of the deal’s value, boosting confidence in its execution capabilities.
- Akums is India’s largest domestic-focused CDMO and the second-largest overall.
- The company benefits from large-scale operations, strong manufacturing capabilities, and an expanding international footprint.
- API price corrections and weaker CDMO revenues in the past year created temporary headwinds, but Citi expects recovery in H1FY26E.
Further, Akums is aggressively expanding its production facilities in Hardwar and Baddi, setting the stage for a more prominent global presence. The company trades at 12x FY27E EBITDA, significantly below its closest competitor, which Citi values at 15x CDMO EBITDA and 10x non-CDMO EBITDA.
Financials: Short-Term Pain, Long-Term Gain?
Akums reported Q3 FY25 revenues of Rs 1,010 crore, down from Rs 1,083 crore in the same quarter last year. Net profit plunged to Rs 66 crore from Rs 195 crore in Q3 FY24, raising concerns about earnings stability.
However, the operating margin improved to 12% from 9%, indicating better cost management despite revenue declines. Key financial metrics include:
| Metric | Q3 FY25 | Q3 FY24 |
|---|---|---|
| Revenue (Rs Cr) | 1,010 | 1,083 |
| Net Profit (Rs Cr) | 66 | 195 |
| Operating Margin | 12% | 9% |
| ROE | 9.8% | N/A |
| ROCE | 7.5% | N/A |
Despite the dip in earnings, Citi believes that the upcoming recovery in CDMO revenues will drive a rebound in valuation.
Should Investors Buy?
Citi’s 36% upside target paints an optimistic picture. However, investors must weigh the short-term financial pressures against the company’s long-term growth strategy. The API pricing environment remains challenging, and near-term earnings volatility is a risk. Yet, Akums’ aggressive expansion, strong CDMO positioning, and valuation discount to peers make it a compelling stock to watch in the Indian pharma space.
One thing’s clear: the next few quarters will be crucial in determining whether Akums lives up to Citi’s expectations.
![gain Rise in Gold Rate in India After Falling Rs 21,200/24K; Will Gold Price Today Jump or Drop on 28 March? By Harshika Yadav Published: Saturday, March 28, 2026, 6:55 [IST] preference Add as a preferred source on Google Gold rates in India witnessed a modest recovery on March 27, 2026, after a sharp fall in the previous session, indicating a cautious stabilisation in the bullion market. The yellow metal had dropped by Rs 212 per gram (or Rs 21,200 per 100 grams) of 24 Karat (24K) earlier, but managed to regain some ground. Gold Price Updates as US-Iran Tensions Ease; Pakistan, Turkiye & Egypt Step Up Mediation Efforts The rise in yellow metal follows easing geopolitical concerns after US President Donald Trump signalled a delay in potential military action against Iran's energy infrastructure by 10 days, pushing the deadline to April 6. This development, along with ongoing diplomatic efforts, has helped support safe-haven demand. gold Rate Today Further adding to market sentiment, Pakistan's Foreign Minister Ishaq Dar confirmed that Islamabad is acting as an intermediary between the United States and Iran, relaying messages as part of efforts to de-escalate tensions. Countries like Türkiye and Egypt are also reportedly supporting the mediation process, offering some relief to global financial markets. Gold Rate in India: Check Latest 22K, 24K & 18K Gold Prices Per Gram 24 Karat Gold Rate Today in India In the 24 Karat segment, at the time of writing, the rate for 1 gram stood at Rs 14,471, rising by Rs 16 from Rs 14,455. For 8 grams, the price increased to Rs 1,15,768, up by Rs 128. The rate for 10 grams climbed to Rs 1,44,710, reflecting a gain of Rs 160, while 100 grams of 24 Karat gold were priced at Rs 14,47,100, marking an increase of Rs 1,600. 22 Karat Gold Rate Today in India The price of one gram of 22K stood at Rs 13,265, gaining Rs 15 from the previous session. For 8 grams, the rate rose to Rs 1,06,120, registering an increase of Rs 120. The cost of 10 grams advanced to Rs 1,32,650, up by Rs 150, while 100 grams were priced at Rs 13,26,500, reflecting a gain of Rs 1,500. 18 Karat Gold Rate Today in India The rate for one gram of 18K stood at Rs 10,853, up by Rs 12. For 8 grams, the price moved up to Rs 86,824, marking a gain of Rs 96. The rate for 10 grams climbed to Rs 1,08,530, increasing by Rs 120, while 100 grams were valued at Rs 10,85,300, reflecting an uptick of Rs 1,200. Latest MCX Gold Price In the domestic futures market, gold on the Multi Commodity Exchange (MCX) held firm above the Rs 1,44,500 level as per latest trading record, supported largely by the weakness in the Indian rupee, which continues to cushion local prices despite global volatility. Latest Spot Gold Rate The rebound in domestic gold rates comes alongside a recovery in international markets, where gold moved above the $4,400 per ounce mark. What Lies Ahead for Gold Prices? Check Gold Rate Prediction Jateen Trivedi, VP - Research Analyst (Commodity and Currency), LKP Securities, said, "Gold remained slightly positive, trading above $4,425 with highs near $4,475, supported by initial optimism around US-Iran talks. However, the sharp rise in crude continues to signal underlying market stress and inflation risks." From a technical perspective, he explained, "Technically, support is seen near Rs 1,42,000, while resistance is placed around Rs 1,46,500. Overall, gold is expected to remain volatile with limited upside unless clarity emerges on inflation and geopolitics."](https://keralanews247.com/wp-content/uploads/2026/03/rupee-and-dollar-scaled-350x250.png)
